SEC EDGAR — 8-K filingsUnited States6 October 2026
8-K - ArriVent BioPharma, Inc. (0001868279) (Filer)
This is an official announcement record
Firsthand records what SEC EDGAR — 8-K filings announced and links to the original. The wording below is theirs, not ours.
Filed: 2026-10-06 AccNo: 0001104659-26-113898 Size: 229 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read the official announcement
Opens www.sec.gov
More from SEC EDGAR — 8-K filings
- 8-K - Onar Holding Corp (0001682265) (Filer)6 October 2026
- 8-K - HUBSPOT INC (0001404655) (Filer)6 October 2026
- 8-K - MAIA Biotechnology, Inc. (0001878313) (Filer)6 October 2026
- 8-K - STRYKER CORP (0000310764) (Filer)6 October 2026
- 8-K - INTERNATIONAL BANCSHARES CORP (0000315709) (Filer)6 October 2026
This content is for informational purposes only and is not financial, investment, tax, or legal advice. Rates, fees, and terms change and may differ from what is shown here; verify current details with the provider before acting. Consider consulting a qualified financial professional about your specific situation.